Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(4):252-253; doi:10.1093/jnci/93.4.252
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hausen, H. z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausen, H. z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 4, 252-253, February 21, 2001
© 2001 Oxford University Press


EDITORIAL

Cervical Carcinoma and Human Papillomavirus: On the Road to Preventing a Major Human Cancer

Harald zur Hausen

Correspondence to: Harald zur Hausen, M.D., D.Sc. (Hon.), Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany (e-mail: zurhausen@dkfz-heidelberg.de).

Three papers in this issue of the Journal cover important aspects of high-risk human papillomavirus (HPV) infections: the infection as an indicator of high-risk lesions (1), strain variation as an indicator for a high risk of disease progression (2), and a phase I clinical trial revealing the potent immunogenicity of the three vaccine preparations tested (3).

The question of HPV identification as a screening tool in comparison to conventional cytology resulted in controversial discussions for quite some time. The article by Solomon et al. (1) reveals that the Hybrid Capture 2TM test for HPV detection has a . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Srinivasan, E. Taioli, and C. C.Ragin
Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis
Carcinogenesis, October 1, 2009; 30(10): 1722 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
A. Morabia
Should an epidemiologist also have been awarded the 2008 Nobel Prize in Medicine?
J Epidemiol Community Health, March 1, 2009; 63(3): 177 - 178.
[Full Text] [PDF]


Home page
J. Virol.Home page
X. Liu, G. L. Disbrow, H. Yuan, V. Tomaic, and R. Schlegel
Myc and Human Papillomavirus Type 16 E7 Genes Cooperate To Immortalize Human Keratinocytes
J. Virol., November 15, 2007; 81(22): 12689 - 12695.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Nonnenmacher, J. Salmon, Y. Jacob, G. Orth, and F. Breitburd
Cottontail rabbit papillomavirus e8 protein is essential for wart formation and provides new insights into viral pathogenesis.
J. Virol., May 1, 2006; 80(10): 4890 - 4900.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Liu, H. Yuan, B. Fu, G. L. Disbrow, T. Apolinario, V. Tomaic, M. L. Kelley, C. C. Baker, J. Huibregtse, and R. Schlegel
The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein
J. Biol. Chem., March 18, 2005; 280(11): 10807 - 10816.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
S. Syrjanen, I. Shabalova, N. Petrovichev, V. Kozachenko, T. Zakharova, J. Pajanidi, J. Podistov, G. Chemeris, L. Sozaeva, E. Lipova, et al.
Acquisition of High-Risk Human Papillomavirus Infections and Pap Smear Abnormalities among Women in the New Independent States of the Former Soviet Union
J. Clin. Microbiol., February 1, 2004; 42(2): 505 - 511.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Lippman and W. K. Hong
Cancer Prevention Science and Practice
Cancer Res., September 15, 2002; 62(18): 5119 - 5125.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
E. S. Calhoun, R. M. McGovern, C. A. Janney, J. R. Cerhan, S. J. Iturria, D. I. Smith, B. S. Gostout, and D. H. Persing
Host Genetic Polymorphism Analysis in Cervical Cancer
Clin. Chem., August 1, 2002; 48(8): 1218 - 1224.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
F X Bosch, A Lorincz, N Munoz, C J L M Meijer, and K V Shah
The causal relation between human papillomavirus and cervical cancer
J. Clin. Pathol., April 1, 2002; 55(4): 244 - 265.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. X. Bosch, N. Munoz, S. de Sanjose, E. L. F. Franco, D. R. Lowy, M. Schiffman, S. Franceschi, S. K. Kjaer, C. J. L. M. Meijer, I. H. Frazer, et al.
Re: Cervical Carcinoma and Human Papillomavirus: On the Road to Preventing a Major Human Cancer
J Natl Cancer Inst, September 5, 2001; 93(17): 1349 - 1350.
[Full Text] [PDF]